Yair Schwarz,Elisabeth Nowak,Reut Halperin et al.
Yair Schwarz et al.
Cushing's disease (CD) is an endogenous hypercortisolism state caused by an adrenocorticotropic hormone (ACTH) secreting pituitary adenoma. Medical therapy is an important second-line treatment for CD. New pharmacologic agents for the treat...
Yair Schwarz,Elisabeth Nowak,Reut Halperin et al.
Yair Schwarz et al.
Cushing's disease (CD) is an endogenous hypercortisolism state caused by an adrenocorticotropic hormone secreting pituitary adenoma. CD is associated with vast comorbidities and has a significant detrimental effect on quality of life as wel...
Mônica R Gadelha,Leandro Kasuki,Carolina Aloan et al.
Mônica R Gadelha et al.
Surgery is the first-line treatment for most patients with acromegaly; however, even in specialized centers, approximately 50% of patients will require adjuvant medical therapy. Three drug classes are currently available for treatment: soma...
Ukasha Habib,Nicholas A Tritos
Ukasha Habib
Nonfunctioning pituitary adenomas (NFPA) account for approximately 30% of clinically evident pituitary tumors in adults and may present with mass effect, including visual compromise, headache, or hypopituitarism. Alternatively, NFPA can be ...
Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas [0.03%]
垂体腺瘤患者的新型影像学模式评估
Kevin A Huynh,James MacFarlane,Waiel A Bashari et al.
Kevin A Huynh et al.
Accurate tumor localization is essential for optimal treatment planning in patients with pituitary adenomas. Recent advances in MRI allow improved detection of sites of de novo and residual disease and can also provide improved visualizatio...
Diagnosis of Cushing's Disease [0.03%]
库欣病的诊断
Henrik Elenius,Lynnette K Nieman
Henrik Elenius
Cushing's disease (CD), the most common cause of Cushing's syndrome (CS), is ideally treated by resection of the underlying ACTH-producing pituitary adenoma. However, it may be difficult to establish that CD is the underlying etiology of CS...
Thyroid Cancer: An Update in Causal Mechanisms, Diagnosis, Initial Treatment, and Long-Term Management [0.03%]
甲状腺癌：病因机制、诊断、初始治疗及长期管理的最新进展
Kenneth D Burman,Jacqueline Jonklaas
Kenneth D Burman
Reza Pishdad,Giuseppe Barbesino,Lori J Wirth
Reza Pishdad
This comprehensive review highlights critical advances in understanding hereditary thyroid cancer syndromes, focusing on familial medullary thyroid cancer and nonmedullary thyroid cancers. It explores genetic underpinnings, particularly REa...
Update on Somatic Genomic Alterations in Follicular Cell-Derived Thyroid Cancers [0.03%]
甲状腺滤泡细胞来源甲状腺癌体细胞基因组改变的更新研究进展
William R Perry,Thomas J Giordano
William R Perry
Since the advent of polymerase chain reaction-based, Sanger, and massive parallel sequencing platforms over the past 4 decades, these technologies have been liberally employed to investigate the genomic profile of every common type of human...
The Interaction Between Sex and Thyroid Cancer Development and Management [0.03%]
性别与甲状腺癌发生和管理之间的相互作用关系
Farah I Kitana,Leila Shobab
Farah I Kitana
This article explores the sex difference in incidence and progression of differentiated thyroid cancer (DTC). The article examines epidemiologic studies highlighting sex disparities in survival rates between men and women, with women experi...